Originally from: lina
                        
We have constructed genetically engineered vaccines
containing only the viral capsid and 3C protease
coding regions from a number of FMDV types in a
replication-defective human adenovirus and have
evaluated their potency and efficacy in animals.

http://www.nfid.org/conferences/vaccine02/absinvited.pdf